More
    Guided Solutions - Connecting Talent With Innovation/div>

    AI programme yields promising results for chest x-rays diagnosing COVID-19

    An Artificial Intelligence (AI) programme created by Bering Limited and study conducted by iCAIRD, Scotland’s Industrial Centre for AI Research in Digital Diagnostics has...

    GLEAMER Receives FDA Clearance for Its Artificial Intelligence Software to Help Detect and Localize Fractures

    GLEAMER, a French MedTech company pioneering the use of artificial intelligence technology in the practice of radiology, announced that the United States Food and...

    Biosensor aiming to cut opioid overdose deaths undergoes clinical trial

    Dundee University is commencing the clinical trial of PneumoWave’s wearable device that aims to reduce the growing number of fatal opioid overdoses in Scotland. John...

    LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep Apnea

    LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the first patient implanted in the investigational device exemption (IDE) clinical...

    Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Center Clinical Trial

    Study will advance the validation of Cellvizio® as a real-time biopsy guidance tool during robotic-assisted bronchoscopy that may reduce the near-miss rate of peripheral...

    Nevro announces publication of 12-month data on high-frequency SCS for non-surgical refractory back pain

    Nevro Corporation has announced online publication of 12-month data from the SENZA-NSRBP randomised controlled trial (RCT) in Journal of Neurosurgery: Spine. These data show that...

    Lungpacer Medical Accelerates Pivotal Clinical Study with AeroPace™ System

    Studying faster ventilator independence with minimally invasive diaphragm strengthening technology. Lungpacer Medical, a leading medical device innovation company, today announced the introduction of the AeroPace™...

    First patients enrolled in trial for Boston Scientific’s SpaceOAR Vue hydrogel

    GenesisCare announced today that it enrolled the first patients in a trial for Boston Scientific’s (NYSE:BSX) SpaceOAR Vue hydrogel. Boston Scientific’s SpaceOAR Vue hydrogel will be evaluated...

    New spinal cord stimulation study puts people with paralysis on their feet again

    Michel Roccati lost the ability to walk after a motorcycle accident in 2017, when he had a complete spinal cord injury. But today, equipped...

    Latest articles